Baxter - 45 Year Stock Price History | BAX
Historical daily share price chart and data for Baxter since 1981 adjusted for splits and dividends. The latest closing stock price for Baxter as of January 14, 2026 is 19.84.
- The all-time high Baxter stock closing price was 83.84 on April 20, 2020.
- The Baxter 52-week high stock price is 37.74, which is 90.2% above the current share price.
- The Baxter 52-week low stock price is 17.40, which is 12.3% below the current share price.
- The average Baxter stock price for the last 52 weeks is 26.64.
| Baxter Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 20.1933 | 19.5000 | 21.0700 | 19.5000 | 19.8400 | 3.82% |
| 2025 | 26.7372 | 28.7401 | 36.0950 | 17.4108 | 19.1100 | -33.28% |
| 2024 | 35.7414 | 37.0890 | 42.0796 | 28.1213 | 28.6419 | -22.40% |
| 2023 | 38.4710 | 47.3253 | 48.7439 | 30.0314 | 36.9076 | -21.91% |
| 2022 | 61.8404 | 79.1600 | 81.5111 | 46.0921 | 47.2604 | -39.58% |
| 2021 | 72.9735 | 71.9957 | 79.4516 | 66.7304 | 78.2215 | 8.48% |
| 2020 | 75.1246 | 76.2819 | 83.8404 | 63.7398 | 72.1036 | -2.93% |
| 2019 | 70.4279 | 57.3970 | 79.5425 | 56.6762 | 74.2832 | 28.40% |
| 2018 | 61.0845 | 58.4310 | 68.1931 | 53.9584 | 57.8540 | 2.89% |
| 2017 | 50.2172 | 38.2612 | 57.3157 | 38.2612 | 56.2301 | 47.30% |
| 2016 | 37.5715 | 31.6335 | 42.2021 | 29.5825 | 38.1751 | 17.58% |
| 2015 | 31.6908 | 33.6824 | 35.6356 | 27.3801 | 32.4675 | -3.58% |
| 2014 | 33.2059 | 31.7893 | 35.3777 | 30.5488 | 33.6731 | 5.38% |
| 2013 | 31.8648 | 31.0817 | 34.1968 | 29.3543 | 31.9548 | 4.34% |
| 2012 | 26.6607 | 23.2206 | 31.6147 | 22.5268 | 30.6269 | 34.72% |
| 2011 | 24.9718 | 23.2251 | 28.6742 | 21.8928 | 22.7335 | -2.25% |
| 2010 | 22.9266 | 26.7812 | 28.3525 | 18.5938 | 23.2573 | -13.74% |
| 2009 | 24.8200 | 25.3063 | 27.7966 | 21.3229 | 26.9604 | 9.50% |
| 2008 | 28.2309 | 26.5514 | 32.6897 | 22.2832 | 24.6218 | -7.68% |
| 2007 | 25.1686 | 21.3642 | 28.0676 | 21.2862 | 26.6709 | 25.14% |
| 2006 | 18.8076 | 17.6243 | 21.6905 | 16.2873 | 21.3137 | 23.21% |
| 2005 | 17.1229 | 15.9060 | 18.8143 | 15.3317 | 17.2981 | 9.00% |
| 2004 | 14.4649 | 13.8614 | 15.8922 | 13.2136 | 15.8692 | 13.17% |
| 2003 | 12.2113 | 13.1815 | 14.3347 | 8.5273 | 14.0222 | 9.00% |
| 2002 | 19.8224 | 24.3965 | 27.3829 | 11.1278 | 12.8644 | -47.79% |
| 2001 | 22.2496 | 20.5889 | 25.4992 | 18.7224 | 24.6400 | 21.46% |
| 2000 | 16.3941 | 14.0464 | 20.3591 | 11.8579 | 20.2873 | 41.13% |
| 1999 | 14.9363 | 14.3922 | 17.3152 | 13.3974 | 14.3753 | -1.86% |
| 1998 | 13.0111 | 11.3551 | 15.0138 | 11.0295 | 14.6484 | 28.20% |
| 1997 | 11.3509 | 9.1475 | 13.5671 | 9.1475 | 11.4259 | 23.76% |
| 1996 | 9.8292 | 9.3052 | 10.7401 | 8.9420 | 9.2320 | -1.38% |
| 1995 | 7.9202 | 6.2350 | 9.5008 | 6.0133 | 9.3611 | 49.47% |
| 1994 | 5.6328 | 5.3449 | 6.3283 | 4.8386 | 6.2628 | 17.17% |
| 1993 | 5.8766 | 6.9198 | 6.9198 | 4.4275 | 5.3449 | -23.95% |
| 1992 | 7.1304 | 7.6922 | 7.8637 | 6.0525 | 7.0284 | -10.34% |
| 1991 | 6.6115 | 5.3364 | 7.9127 | 4.9953 | 7.8392 | 44.26% |
| 1990 | 4.7845 | 4.9396 | 5.6455 | 4.0017 | 5.4339 | 12.21% |
| 1989 | 4.1548 | 3.4042 | 4.9570 | 3.4042 | 4.8428 | 42.26% |
| 1988 | 4.0009 | 4.5148 | 4.9977 | 3.1869 | 3.4042 | -22.53% |
| 1987 | 4.6682 | 3.6533 | 5.6186 | 3.5448 | 4.3941 | 18.71% |
| 1986 | 3.4800 | 2.9646 | 4.0462 | 2.9169 | 3.7014 | 22.87% |
| 1985 | 2.7844 | 2.4952 | 3.1701 | 2.3873 | 3.0125 | 20.73% |
| 1984 | 3.0884 | 4.3968 | 4.6332 | 2.2813 | 2.4952 | -43.25% |
| 1983 | 5.0535 | 4.3773 | 5.9150 | 4.0389 | 4.3968 | -3.71% |
| 1982 | 3.6592 | 3.2280 | 4.7653 | 2.9466 | 4.5661 | 44.62% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $10.101B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.142B | 24.91 |
| EssilorLuxottica (ESLOY) | France | $149.893B | 0.00 |
| Boston Scientific (BSX) | United States | $139.557B | 31.91 |
| Stryker (SYK) | United States | $136.074B | 27.02 |
| Medtronic (MDT) | Ireland | $123.612B | 17.13 |
| Medline (MDLN) | United States | $56.293B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.245B | 0.00 |
| Agilent Technologies (A) | United States | $41.482B | 26.22 |
| GE HealthCare Technologies (GEHC) | United States | $38.615B | 18.47 |
| ResMed (RMD) | United States | $37.167B | 25.72 |
| Koninklijke Philips (PHG) | Netherlands | $28.531B | 18.64 |
| Terumo (TRUMY) | Japan | $21.128B | 23.78 |
| Insulet (PODD) | United States | $19.568B | 60.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.507B | 10.92 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.553B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.690B | 31.25 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| BillionToOne (BLLN) | United States | $4.433B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.366B | 13.30 |
| Envista Holdings (NVST) | United States | $3.820B | 21.92 |
| Haemonetics (HAE) | United States | $3.690B | 16.42 |
| ICU Medical (ICUI) | United States | $3.661B | 23.24 |
| Prestige Consumer Healthcare (PBH) | United States | $3.111B | 14.19 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.262B | 14.54 |
| Perrigo (PRGO) | Ireland | $2.073B | 5.19 |
| Neogen (NEOG) | United States | $1.999B | 43.76 |
| LeMaitre Vascular (LMAT) | United States | $1.891B | 38.06 |
| AtriCure (ATRC) | United States | $1.810B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.784B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.742B | 76.36 |
| Phibro Animal Health (PAHC) | United States | $1.640B | 16.38 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.515B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.437B | 20.80 |
| Kestra Medical Technologies (KMTS) | United States | $1.286B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.151B | 341.43 |
| Capricor Therapeutics (CAPR) | United States | $1.133B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.054B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.028B | 0.00 |
| Omeros (OMER) | United States | $0.895B | 0.00 |
| InMode (INMD) | Israel | $0.887B | 10.02 |
| Valneva SE (VALN) | France | $0.864B | 0.00 |
| CeriBell (CBLL) | United States | $0.845B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.564B | 15.30 |
| Cerus (CERS) | United States | $0.484B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.476B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.472B | 0.00 |
| Brainsway (BWAY) | Israel | $0.467B | 79.45 |
| Canopy Growth (CGC) | Canada | $0.461B | 0.00 |
| SNDL (SNDL) | Canada | $0.434B | 0.00 |
| Evolus (EOLS) | United States | $0.371B | 0.00 |
| Quanterix (QTRX) | United States | $0.334B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.295B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 21.97 |
| Sanuwave Health (SNWV) | United States | $0.245B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.33 |
| TerrAscend (TSNDF) | Canada | $0.236B | 0.00 |
| High Tide (HITI) | Canada | $0.235B | 0.00 |
| Organigram Global (OGI) | Canada | $0.228B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.211B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.197B | 0.00 |
| Accendra Health (ACH) | United States | $0.194B | 1.95 |
| Utah Medical Products (UTMD) | United States | $0.188B | 16.54 |
| OraSure Technologies (OSUR) | United States | $0.187B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.117B | 0.00 |
| Exagen (XGN) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.76 |
| Biote (BTMD) | United States | $0.111B | 4.86 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Sharps Technology (STSS) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.58 |
| Nephros (NEPH) | United States | $0.047B | 34.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| Veru (VERU) | United States | $0.039B | 0.00 |
| Jin Medical (ZJYL) | China | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.57 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.014B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |